PNOC041: Metformin in Patients with Recurrent or Progressive PFA Ependymoma

Who Can Participate in the Study?

Age Group
Both

Study Details

Full Title
PNOC041: A Target Validation and Efficacy Study of Metformin in Patients with Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma
Principal Investigator
Headshot of Daniel Bryce Landi
Associate Professor of Pediatrics
Protocol Number
IRB: PRO00119661
NCT: NCT07226453
Phase
Phase I/II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate